Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11524 posts found.

Schering-Plough sacrifices begin with Hassan’s bonus

October 29, 2003 Sales and Marketing

Schering-Plough's new chief executive and chairman Fred Hassan, has forgone a bonus of up to $2 million bonus to demonstrate …
News

Call for free price-setting across Europe

October 29, 2003 Sales and Marketing

Pharmaceutical companies should be allowed to set their own prices in all the European Union countries in order to bring …
News

Hassan hits the ground running on Schering-Plough re-organisation

October 28, 2003 Sales and Marketing

Fred Hassan has announced a major re-organisation of Schering-Plough's pharmaceutical operations just 17 days after taking on the job of …
News

UK’s pharmaceutical profit control scheme to be reviewed

October 28, 2003 Sales and Marketing

The agreement between the UK government and the pharmaceutical industry which controls company profits is to be reviewed.Introduced in 1999, …
News

Roche launches first proactive patient helpline

October 28, 2003 Medical Communications, Sales and Marketing

Roche and health call-centre specialists International SOS have launched the UK's first ever helpline to proactively support patients to keep …
News

GSK’s ‘sleeping giant’ awakens in US

October 28, 2003 Sales and Marketing

News

European HRT safety probe launched

October 28, 2003 Sales and Marketing

The European Union medicines regulator is to investigate the safety of hormone replacement therapy products following a new study was …
News

Generics begin assault on Zocor

October 28, 2003 Sales and Marketing

News

New data boosts AstraZeneca’s Atacand

October 28, 2003 Research and Development, Sales and Marketing

New trial data on AstraZeneca's blood pressure treatment Atacand could give the drug a lead over rivals in the same …
News

UK pharma sends aid to Iraq

October 28, 2003 Sales and Marketing

News

Femara heralded as breakthrough in breast cancer

October 28, 2003 Sales and Marketing

Compelling new evidence showing Novartis' Femara reduces the risk of breast cancer recurring in patients has been heralded as a …
News

Risk-sharing agreement failing MS patients

October 28, 2003 Sales and Marketing

News

FDA clears Iressa of safety concerns

October 28, 2003 Sales and Marketing

AstraZeneca's lung cancer drug Iressa has gained US approval after an extended review found the drug to be safe, despite …
News

GSK to remove Seroxat ‘not addictive’ claim

October 28, 2003 Sales and Marketing

GlaxoSmithKline is to drop claims on patient information leaflets that its antidepressant Seroxat is not addictive.The admission is to be …
News

AZ promise despite Losec drop

October 28, 2003 Sales and Marketing

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026